Literature DB >> 34089617

Blockade of checkpoint ILT3/LILRB4/gp49B binding to fibronectin ameliorates autoimmune disease in BXSB/Yaa mice.

Mei-Tzu Su1, Masanori Inui1, Yi Li Wong1, Maika Takahashi1, Akiko Sugahara-Tobinai1, Karin Ono1, Shotaro Miyamoto1, Keiichi Murakami1, Ari Itoh-Nakadai1, Dai Kezuka1, So Itoi1, Shota Endo1, Kouyuki Hirayasu2,3,4, Hisashi Arase3,4, Toshiyuki Takai1.   

Abstract

The extracellular matrix (ECM) is the basis for virtually all cellular processes and is also related to tumor metastasis. Fibronectin (FN), a major ECM macromolecule expressed by different cell types and also present in plasma, consists of multiple functional modules that bind to ECM-associated, plasma, and cell-surface proteins such as integrins and FN itself, thus ensuring its cell-adhesive and modulatory role. Here we show that FN constitutes an immune checkpoint. Thus, FN was identified as a physiological ligand for a tumor/leukemia/lymphoma- as well as autoimmune-associated checkpoint, ILT3/LILRB4 (B4, CD85k). Human B4 and the murine ortholog, gp49B, bound FN with sub-micromolar affinities as assessed by bio-layer interferometry. The major B4-binding site in FN was located at the N-terminal 30-kDa module (FN30), which is apart from the major integrin-binding site present at the middle of the molecule. Blockade of B4-FN binding such as with B4 antibodies or a recombinant FN30-Fc fusion protein paradoxically ameliorated autoimmune disease in lupus-prone BXSB/Yaa mice. The unexpected nature of the B4-FN checkpoint in autoimmunity is discussed, referring to its potential role in tumor immunity. © The Japanese Society for Immunology. 2021. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  B-cell development; auto-antibody; immune checkpoint; systemic lupus erythematosus; tolerance

Mesh:

Substances:

Year:  2021        PMID: 34089617     DOI: 10.1093/intimm/dxab028

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  3 in total

1.  Upregulation of leukocyte immunoglobulin-like receptor B4 on interstitial macrophages in COPD; their possible protective role against emphysema formation.

Authors:  Ayumi Mitsune; Mitsuhiro Yamada; Naoya Fujino; Tadahisa Numakura; Tomohiro Ichikawa; Ayumi Suzuki; Shuichiro Matsumoto; Yoshiya Mitsuhashi; Koji Itakura; Tomonori Makiguchi; Akira Koarai; Tsutomu Tamada; Shota Endo; Toshiyuki Takai; Yoshinori Okada; Satoshi Suzuki; Masakazu Ichinose; Hisatoshi Sugiura
Journal:  Respir Res       Date:  2021-08-23

2.  LILRB4 promotes tumor metastasis by regulating MDSCs and inhibiting miR-1 family miRNAs.

Authors:  Mei-Tzu Su; Sakiko Kumata; Shota Endo; Yoshinori Okada; Toshiyuki Takai
Journal:  Oncoimmunology       Date:  2022-04-05       Impact factor: 8.110

Review 3.  LILRB4, an immune checkpoint on myeloid cells.

Authors:  Ting Yang; Yixin Qian; Xiaoting Liang; Jianbo Wu; Ming Zou; Mi Deng
Journal:  Blood Sci       Date:  2022-05-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.